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Introduction
The mediastinum is a site for a wide range of various 
neoplasms, with often rare histologies (1,2), imposing 
both diagnostic and therapeutic challenges. Particularly 
large mediastinal masses, or intrathoracic masses with 
mediastinal compression, offer surgical challenges, due to 
the complex anatomy of the mediastinum, with obstruction, 
compression, or invasion of vital surrounding structures. 
In addition, anesthesiological management during surgery 
can be complicated by the so-called “mediastinal mass 
syndrome” (MMS) (3), characterized by acute respiratory 
and hemodynamic decompensation, due to mechanical 
compression of mediastinal structures. Therefore, 
meticulous preoperative assessment, preparation and 
collaboration between the surgeon and anesthesiologist are 
essential.
In  th i s  paper ,  we  d i s cus s  cons idera t ions  and 
recommendations regarding perioperative preparation 
and management in patients with large masses involving 
or compressing the mediastinum (Figure 1). Due to the 
rarity of mediastinal tumors, especially large masses, little 
literature is available regarding this matter. The current 
manuscript is based on a review of the literature and our 
own clinical experience.
Preoperative preparation
Tumors involving the mediastinum include a wide 
variety of histologies, both benign and malignant in 
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nature. Differential diagnoses can be divided based 
upon the localization in the three different mediastinal 
compartments. Excellent reviews are available regarding 
the various approaches for distinguishing and diagnosing 
different mediastinal tumors (1,2), and this subject is beyond 
the scope of this paper.
Roughly 40% of all tumors involving the mediastinum 
are asymptomatic at presentation (4). Consequently, these 
masses regularly grow to such a size that determination 
of the site of origin is challenging. Regardless of the 
definitive diagnosis, the exact size or location, all large 
mediastinal and intrathoracic masses may cause mechanical 
compression of vital mediastinal structures, purely due to 
the sheer weight and volume of the tumor. Acute or chronic 
respiratory insufficiency may occur with compression of the 
airways, i.e., trachea, bronchi or both (5). Hemodynamic 
decompensation can be caused by compression of the heart 
or major vessels in the mediastinum. These effects, also 
called MMS, can be greatly aggravated by induction of 
anesthesia (3) or positional changes during surgery. The 
exact incidence of perioperative MMS remains unknown, 
and reporting is limited to isolated cases (3). Nevertheless, 
insufficient preoperative preparations and inadequate 
perioperative management can promptly lead to life-
threatening situations (3). Therefore, careful diagnostic 
workup and detailed preoperative imaging is essential in 
all cases to assess the anatomy and exact relationship of the 
tumor with the surrounding vital mediastinal structures. 
Furthermore, as the size of the tumor can both complicate 
surgical resection and anesthetic management, effort should 
Multidisciplinary case discussion with the surgeon, respiratory physician,  
oncologist, radiologist, pathologist, and radiation experts
↓
Diagnostic studies
Anatomical assessment Vascular assessment
• High-resolution CT-angiography with narrow slice width  
(sections 1–2 mm thickness), followed by multiplanar reconstruction
• Consider ECG-gated CT or MRI
• Consider TTE/TEE
• Consider bronchoscopy
• Consider (coronary) angiography
↓
Reduce tumor size
• Consider neoadjuvant chemotherapy and/or radiation therapy
• Consider embolisation of tumor vessels
↓
Preoperative case discussion with surgeon and anesthesiologist
• Surgical access and approach
• Positioning of the patient (determine “rescue” position)
• Estimation of the risk of MMS
• Potential need for extracorporeal circulation support
↓
Anesthesiological considerations
• Maintenance of spontaneous ventilation, awake fiberoptic intubation
• Short-acting medications
• Large-bore venous access in the lower extremity
• Consider double-lumen intubation
• Consider intraoperative TEE
• Prepare for potential need of intraoperative rigid bronchoscopy
↓
Surgical resection
Figure 1 Recommendations for preoperative assessments prior to surgical treatment of large mediastinal tumors or intrathoracic tumors 
with mediastinal compression. ECG, electrocardiography; CT, computed tomography; MRI, magnetic resonance imaging; TTE, 
transthoracic echocardiography; TEE, transesophageal echocardiography; MMS, mediastinal mass syndrome.
E177Journal of Thoracic Disease, Vol 8, No 3 March 2016
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2016;8(3):E175-E184jtd.amegroups.com
be undertaken to reduce tumor volume before definitive 
operative therapy.
Anatomical assessment of the mediastinum
Traditionally, following chest radiography, computed 
tomography (CT) of the chest is the initial choice 
of imaging modality in the evaluation of mediastinal 
masses (6). It is valuable in demonstrating the morphology 
of the tumor, its exact anatomical location, and its relation 
with structures in the mediastinum. We prefer the use of 
high-resolution CT-angiography with narrow slice width 
(sections 1–2 mm thickness), followed by multiplanar 
reconstruction. The use of intravenous contrast is important 
in delineating the vasculature of the tumor and its direct 
surroundings.
While CT is superior in spatial resolution, detection 
of  ca lc i f i ca t ion and bony destruct ion,  magnet ic 
resonance imaging (MRI) is more adequate in soft tissue 
differentiation and delineating tissue boundaries. MRI has 
been suggested to be more accurate in diagnosing invasion 
of the mediastinum (7,8) and chest wall (8) when compared 
to CT. Furthermore, blood vessels are identifiable without 
the need for intravenous contrast enhancement, and 
could be helpful in patients who cannot receive iodinated 
intravenous contrast.
The heart takes a central position in the mediastinum. 
Subsequently,  cardiac motion artifacts may cause 
misinterpretation of the images produced by standard 
CT or MRI, especially in evaluating structures close to 
the heart. Recently, the advance of electrocardiogram 
(ECG)-gated cardiac CT and ECG-gated cardiac MRI 
has produced superior image quality with nearly artifact-
free images, greatly improving the assessment of cardiac 
tumors and its relations to adjacent structures. In addition 
to these static images, dynamic MRI with dynamic 
cinematic displays of cardiac motion can provide essential 
complementary information regarding cardiac involvement 
or tumor invasion (9). Both cardiac CT and cardiac MRI 
have been recommended by the American College of 
Cardiology Foundation for clinical evaluation of cardiac 
masses, extracardiac structures, and involvement and 
characterization of these masses (10,11). Conversely, the 
relationship of central mediastinal tumors with the heart 
and cardiac structures can potentially be much more reliably 
evaluated with these new imaging techniques.
T r a n s t h o r a c i c  e c h o c a r d i o g r a p h y  ( T T E )  a n d 
transesophageal echocardiography (TEE) are standard 
diagnostic imaging modalities in the perioperative setting 
of cardiac surgery. For the evaluation of mediastinal masses, 
its role is less defined. However, with the central position 
of the heart in the mediastinum, large mediastinal tumors 
can cause significant compression or even invasion of the 
heart (12-14). Echocardiography offers complimentary 
information to CT and MRI images when assessing 
encroachment or compression of cardiac structures by the 
mediastinal mass (15), and when distinguishing between 
pericardial and intracardiac tumors. In any case, we 
advise to perform a routine preoperative TTE to evaluate 
cardiac structure and function as part of preoperative risk 
assessment.
Fluorodeoxyglucose positron emission tomography 
(FDG-PET) has an increasing role in the diagnostic 
pathway evaluating mediastinal tumors (16), with impact 
on diagnosis, staging and prognosis. However, FDG-PET 
adds little additional information regarding the anatomical 
assessment of the mediastinum.
Regarding invasive diagnostic procedures, bronchoscopy 
is an important tool, both in the preoperative assessment as 
in the operating room. Flexible bronchoscopy can visualize 
the trachea, proximal airways, and segmental airways to 
evaluate potential extrinsic airway compression from large 
mediastinal masses. If airway compression is present, the 
patient usually has a position preference. Anticipating the 
positional changes during surgery, the severity of airway 
compression in different positions can be evaluated during 
bronchoscopy.
Vascular assessment of the mediastinum
Large tumors, especially in the mediastinum, can be 
highly vascularised, complicating surgical resection. For 
example, in a series of 34 patients with a solitary fibrous 
tumor (SFT) (17), 35% had large collateral feeding vessels 
which could be seen on CT, MRI, and angiography. 
Blood supply to mediastinal masses has been reported 
to be highly variable, possibly derived from branches 
from the internal mammary artery (18-20), bronchial 
arteries (19), thyrocervical trunk (19,20), intercostal 
vessels (21), phrenic nerve vessels, pulmonary artery, and 
even from coronary arteries (22-26). These large feeding 
vessels may cause technical and bleeding complications 
during surgical resection. Therefore, it is advisable to be 
maximally informed regarding the vascularisation prior 
to surgery, either through MRI or high-resolution CT 
with intravenous contrast with multiplanar reconstruction. 
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Angiography, i.e., pulmonary angiography or occasionally 
coronary angiography is also a valuable diagnostic modality 
to assess the vasculature of large tumors involving the 
mediastinum. In addition, during angiography, embolization 
of these feeding vessels can be performed before operative 
treatment, and can theoretically be useful in order to reduce 
blood loss during surgery. This has been done in several 
reported cases (17,19,20,22,27,28), although no definitive 
evidence exists that this will indeed lower perioperative 
bleeding complications.
In the setting of compression or invasion of the vena cava 
by large mediastinal tumors, the venous circulation will be 
maintained through collateral vessels (29,30). Similarly to 
large feeding vessels, the presence of large venous collaterals 
can also cause significant surgical bleeding complications. 
Again, contrast-enhanced, high-resolution CT with 
multiplanar and 3D reconstruction is an excellent technique 
in portraying the collateral circulation (31) to facilitate an 
optimal surgical strategy.
Reducing tumor size
Depending on the histological diagnosis, neoadjuvant 
therapy can be important in reducing tumor mass and 
surrounding infiltration, potentially leading to resectability 
in initially inoperable cases, or greatly facilitating 
surgical resection. For instance, for primary mediastinal 
nonseminomatous germ cell tumors, multimodality 
treatment is the approach of choice, consisting of 
neoadjuvant chemotherapy followed by surgical resection 
of residual disease (32). In thymomas, neoadjuvant 
chemotherapy and radiotherapy is successful in achieving 
volume reduction preoperatively (33). A recent survey 
among members of the European Association for Cardio-
Thoracic Surgery revealed that neoadjuvant therapy was 
used by most surgeons in the treatment of thymoma, and is 
significantly more utilized by high-volume surgeons (34).
Making a histopathological diagnosis through fine-
needle aspiration (FNA) or core needle biopsy is important 
in guiding decision-making in this regard. Various methods 
are available (35), depending on the location of the mass, 
including TTE approaches with image-guidance by 
CT (36) or ultrasound, guidance by endobronchial (37) and 
transesophageal ultrasound, or surgical methods including 
mediastinoscopy and mediastinostomy. However, the role 
of obtaining tissue diagnosis in the evaluation of mediastinal 
masses remains to be controversial due to the fear of tumor 
cell seeding in the biopsy tract, especially when thymic 
neoplasms are likely (38,39). As proposed by the National 
Comprehensive Cancer Network Guidelines on thymic 
malignancies (39), surgical biopsy should be avoided if a 
resectable thymoma is strongly suspected based on clinical 
and radiologic features. If biopsy is performed, transpleural 
approaches should be avoided.
Furthermore, as mediastinal tumors often comprise 
rare histological entities, evidence is not always available 
to guide the utilization of neoadjuvant therapy, even 
when a pathological diagnosis is available. In this regard, 
FDG-PET has become an increasingly important tool. 
Although the additional anatomical information obtained 
by FDG-PET is insufficient, the metabolic activity of the 
mass has been shown to predict the response of the tumor 
to neoadjuvant therapy in various malignancies (40-43). 
Furthermore, cellular markers for the level of proliferation 
activity (like mitotic and apoptotic index) could also be used 
to predict response to neoadjuvant therapy (44). Decisions 
about the value of neoadjuvant therapy should be based on 
multidisciplinary discussion with the surgeon, respiratory 
physician, oncologist, radiologist, pathologist, and radiation 
experts.
As mentioned earlier, embolisation of afferent vessels 
has been performed in order to reduce surgical bleeding 
complications. However, whether this technique can also 
reduce tumor size and volume remains to be investigated. 
Uterine artery embolization for symptomatic uterine 
fibroids has been reported to be effective (45), resulting 
in infarction of fibroids, with reduction of volume and 
complaints.  Furthermore, chemoembolisation has 
become an accepted treatment option for hepatocellular 
carcinoma, usually as a palliative technique (46). It 
involves the combined intra-arterial administration of 
cytotoxic anticancer drugs and embolisation agent into a 
liver tumor, inducing extensive tumor necrosis. Whether 
these embolisation techniques could be successful as a 
neoadjuvant tumor reduction modality in large mediastinal 
tumors, remains to be an interesting area for future 
research.
Anesthesiological considerations
Patients with large mediastinal masses pose significant 
anesthesiological challenges due to the possible occurrence 
of MMS (3,47). Prior to definitive surgical resection, a 
thorough perioperative plan should be made between the 
surgeon and anaesthesiologist (3,47,48). Preoperative risk 
assessment by the anesthesiologist is essential, based on 
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clinical, functional, bronchoscopic, and radiological data, 
with emphasis on the anatomical details of the tumor 
and its relation with the surroundings. Detailed history 
taking could reveal symptoms of airway compromise such 
as cyanosis, stridor, dyspnea at rest, postural dyspnea and 
orthopnea. Cardiovascular symptoms may result from 
compression of the great vessels or the heart itself. All these 
symptoms should be evaluated prior to surgery in different 
positions with the patient awake, especially the supine and 
lateral decubitus position. It is important to determine a 
“rescue position”—the position the patient finds the most 
comfortable in terms of complaints, with the most ideal 
respiratory and hemodynamic functioning.
After preoperative assessment, patients may be 
distributed into different risk categories (3). Low risk 
patients are asymptomatic or have minimal symptoms. 
Intermediate risk patients have mild to moderate postural 
symptoms, and tracheobronchial compression <50%. High 
risk patients include patients with severe postural symptoms, 
tracheobronchial compression >50% or tracheobronchial 
compression with associated hemodynamic symptoms. This 
risk stratification may guide the utilization of perioperative 
pre-emptive measures and precautions, like the safest 
form of anesthesia, the optimal positions for induction of 
anesthesia and surgery, the additional value of intraoperative 
(rigid) bronchoscopy and TEE, and the potential assistance 
of extracorporeal circulation (ECC). Furthermore, due to 
the possible involvement of the superior vena cava (SVC) in 
large mediastinal masses, large-bore venous access should be 
secured in the lower extremity (preferably the femoral vein) 
rather than the upper extremity in all patients, regardless 
of risk category. Also, from the surgeon’s point of view, we 
prefer double-lumen endobronchial intubation whenever 
feasible, as intentional unilateral pulmonary collapse could 
greatly facilitate tumor dissection in most cases.
In general, low risk patients tolerate general anaesthesia 
without problems. Patients with intermediate or high risk 
need an individualized approach. Our preferred approach 
for airway management is maintenance of spontaneous 
ventilation, combined with awake fiberoptic intubation. 
Furthermore, with the fiberoptic scope, airway collapse 
or obstruction can be assessed. This can be performed in 
various positions of the operating table in order to further 
determine the optimal rescue position. Finally, the use of 
short-acting medications is recommended for prompt and 
precise control of the level of general anesthesia (3,47).
When intraoperative acute respiratory and hemodynamic 
decompensation does occur, and the possibility of a surgical 
bleeding issue has been properly addressed, mechanical 
compression of vital mediastinal structures should be 
relieved immediately. First of all, the operating table 
should be rapidly tilted to the before determined rescue 
position. In the event of airway compression or obstruction, 
rigid bronchoscopy has been suggested as a method to 
secure the airway past the site of the problem. For initial 
hemodynamic stabilisation, the basic principles of cardiac 
tamponade treatment should be followed, including the 
administration of appropriate fluids, vasopressive and 
inotrope medication. Furthermore, always consider the 
surgeon’s ability to elevate the mass physically from the 
compromised structures.
The definite rescue modality when MMS occurs is ECC, 
providing an avenue for both oxygenation and circulatory 
support. Earlier reports have described “stand-by” ECC as 
a rescue measure (49-51) for intraoperative hemodynamic 
or respiratory deteoriation. However, even with a primed 
ECC circuit and perfusionist present in the operating room, 
it will still take 5–20 minutes before emergency cannulation 
of the femoral vessels is performed and ECC is initiated (48); 
an interval likely to result in significant neurological injury. 
Therefore, several authors have recommended femoral 
cannulation under local anesthetics and initation of ECC 
before induction of anesthesia (3,48), especially in patients 
with high risk of MMS and are deemed “uncertain” or 
“unsafe” according to the classification proposed by Erdös 
and Tzanova (3,48).
Surgical approach
Approach
Various surgical approaches are available to access the 
mediastinal and thoracic cavity. In the surgical management 
of large mediastinal tumors, a midline approach through a 
sternotomy, or a lateral approach through a thoracotomy 
are most often utilized, and less frequently a classic 
clamshell or hemi-clamshell incision. Although resection 
through robot-assisted and video-assisted thoracic surgery 
(VATS) have become increasingly popular (52,53), these 
techniques seem unsuitable for large masses (53), especially 
for tumors larger than 10 cm (53).
In our center, we advocate a midline approach through a 
median sternotomy whenever feasible. Median sternotomy, 
with the patient in supine position, is the gold standard 
for most cardiac operations, and has become increasingly 
popular for bilateral pulmonary procedures, with proper 
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exposure of the hilar structures. It provides a wider surgical 
field for the approach of the anterior mediastinum when 
compared to an anterior or anterolateral thoracotomy. 
This midline approach can be extended to a hemiclamshell 
incision, combining a partial vertical median sternotomy 
with an anterior thoracotomy, for even better visibility of 
especially the posterior hilum, including the lower lobe. In 
the majority of cases, we believe this approach is favorable 
comparing to a lateral approach regarding positioning of the 
patient, proximal central vascular control, and the ease of 
connecting ECC. Although cardiac compression may occur 
in the supine position in the setting of large tumors of the 
anterior mediastinum, this should have become apparent 
with history taking and during routine physical examination 
in the ward, and appropriate precaution measurements can 
be undertaken. In these cases, it is feasible to cannulate 
the femoral vessels under local anesthesia in readiness for 
ECC, even before induction of anesthesia. Furthermore, 
anticipating the need for ECC for hemodynamic support 
in the occurrence of MMS, the supine position would also 
greatly facilitate the approach to the femoral vessels for 
cannulation.
In addition to the positional advantages and ease of 
connection to ECC in the supine position, a midline 
approach also facilitates the access to the hilar structures 
for both proximal vascular control and dissection of the 
anterior extent of mediastinal tumor. During dissection 
of large mediastinal masses, feeding vessels could tear due 
to sheer stress caused by manipulation, leading to serious 
hemorrhagic complications which are hard to control. 
Appropriate precautions can be undertaken, based on 
the information provided by preoperative multimodality 
imaging regarding the vascular anatomy of the tumor. In 
these cases, intrapericardial or proximal control of the main 
pulmonary artery and pulmonary veins is easier through 
a midline approach, and may be necessary before more 
peripheral dissection can be started.
When the tumor extends to the pleural cavity, exposure 
can be improved by applying a retractor to the sternal 
edge (54), which is commonly used during internal 
mammary artery harvesting for coronary artery bypass 
grafting (CABG). This allows constant upward and outward 
retraction of the chest wall. For optimal stabilisation of large 
mediastinal masses, heart positioners can be used which 
are popularized for use in off-pump CABG procedures for 
stabilisation of the heart through suction devices. When 
used in the setting of large mediastinal masses (55), damage 
to the tumor by manipulation of surgical instruments can be 
minimalized, while providing a stable retraction of the mass, 
and reducing the risk of sheer stress on feeding vessels.
Extracorporeal circulation (ECC)
From the surgeon’s point of view, the assistance of ECC 
can greatly facilitate dissection of the tumor, with the 
possibility to safely deflate the lungs and to retract the 
heart, enhancing exposure of the tumor. Also, greater 
manipulation of the tumor can be achieved without the 
risk of hemodynamic or respiratory consequences due to 
compression of vital mediastinal structures. However, the 
need for systemic heparinization during ECC could increase 
the risk of hemorrhagic complications during dissection 
of the tumor. Therefore, a case-by-case preoperative risk 
assessment should be made to assess the need of ECC, and 
in which period of the surgical setting.
Cannulation of the ascending aorta, right atrium or both 
superior and inferior vena cava, as routinely used in most 
cardiac procedures, seem inappropriate during surgery for 
large mediastinal masses. Involvement of cardiovascular 
structures of the mediastinum is common in this setting, 
complicating exposure of the usual sites for central 
cannulation. Furthermore, the cannulas needed for ECC 
could become cumbersome and obstructive for the surgeon 
during prolonged tumor dissection. Therefore, peripheral 
cannulation of the femoral vessels (3,48,50) is advised when 
ECC is deemed necessary or helpful.
From the oncologist’s point of view, the use of ECC 
during oncological surgery is poorly reported. A recent 
systematic review of the use of ECC during surgical 
resection for patients with locally advanced lung cancer 
yielded only 72 patients (56). They found that extended 
resections of locally advanced lung cancer is feasible with 
the help of ECC, although beforehand planning of the use 
of ECC was associated with significantly higher survival 
than cases where unplanned or emergent placement of ECC 
was necessary.
Involvement of the SVC
All tumors involving the mediastinum, especially large 
masses, have the potential to involve or invade the great 
vessels within this confined space. Of these great vessels, the 
SVC is the most commonly affected (57,58), with varying 
extent of involvement, ranging from partial compression or 
invasion, to the development of a SVC syndrome (59). The 
exact incidence of SVC involvement in mediastinal tumors 
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is unknown, due to the relative rareness of this pathology. 
Several small case series have reported an occurrence rate 
of 10% in mediastinal seminomas (60). In a series of 89 
patients with invasive primary mediastinal tumors who 
underwent surgical resection, 24% underwent resection of 
the SVC (57). In a more recent multi-institutional Italian 
series with 249 patients with stage III thymic tumours, 
12.4% had preoperative SVC involvement. Traditionally, 
involvement of great vessels by thoracic tumors has long 
been considered inoperable (61), with infavorable long-
term outcomes. However, with improving techniques, 
resection and reconstruction of the SVC is nowadays the 
most accepted extended vascular resection for mediastinal 
great vessel involvement. However, detailed preoperative 
and operative planning is required.
Depending on the extent of involvement, partial resection 
of the SVC can be performed or even complete resection 
followed by reconstruction with prosthetic grafts or vein 
grafts. Spaggiari advocated partial resection if less than 50% 
of the circumference of the SVC is affected, with pericardial 
patch repair when needed (62). Although partial resection 
can be performed with partial clamping alone when SVC 
involvement is minimal, crossclamping of the SVC is the 
most utilized technique for reconstruction (63). Systematic 
heparinization should be initiated before clamping 
(57,62,63). However, SVC crossclamping is associated with 
important hemodynamic compromise in 30% of patients (63). 
In this setting, intraoperative vasoconstrictive agents and 
appropriate fluid loading are important in increasing venous 
return to the heart and maintaining intracranial cerebral 
perfusion pressure (57,62,63). Correspondingly, angiotensin 
converting enzyme inhibitors and angiotensin II receptor 
antagonists should be discontinued preoperatively to avoid 
intraoperative hypotension and hypovolemia. Moreover, 
SVC crossclamping can cause cerebral ischemia even 
without observable changes in blood pressure or venous 
oxygen saturation (64). Therefore, when SVC involvement 
is suspected preoperatively, we recommend standard 
additional monitoring modalities to assess adequacy of 
cerebral perfusion, preferably cerebral oximetry with 
near-infrared spectroscopy (NIRS) (64,65) or transcranial 
doppler (66), in combination with simultaneous monitoring 
of jugular vein pressure (65).
The time limit to safely perform SVC crossclamping 
remains unclear. Various authors have reported that 
crossclamping of the SVC can be performed for 60 
minutes (61,67) and even up to 100 minutes (67) without 
neurological complications, with or without pre-existing 
SVC obstruction. However, we prefer the application of 
a simple, passive bypass technique from the innominate 
vein to the right atrium with a heparin-coated shunt 
(Gott shunt) (68), obviating the need for additional 
heparinization. Because clamping of the SVC raises the 
pressure gradient between the innominate vein and the 
right atrium, a pumping device is not necessary. This simple 
technique avoids hemodynamic instability and cerebral 
ischemia due to venous hypertension.
Organization of care
Centralisation of care for patients with rare malignancies 
has been advocated (69) in order to improve quality 
of  care and outcome. This  should also apply for 
mediastinal tumors, especially regarding large masses in 
the mediastinum. As discussed before, the preoperative 
workup and intraoperative management of these tumors is 
challenging, and a dedicated multidisciplinary approach is 
essential. Concentration in specialized centers is important 
for the development of expertise, and the facilitation of 
training and research. These intended centers should have 
regular multidisciplinary team meetings with the presence 
of surgeons, oncologists, radiologists, pathologists, and 
radiation experts specialized in respiratory medicine. A 
team of anesthesiologists should be available, dedicated to 
perioperative cardiovascular and cardiothoracic care. With 
the potential need for ECC, the operation should be headed 
by cardiothoracic surgeons or thoracic surgeons with 
cardiac surgery on-site.
For example, in the treatment of thymoma, it has been 
noted that high-volume surgeons are significantly more 
often working with dedicated anesthesiologists, and are 
more likely to have access to a tissue bank for research 
purposes (34). However, an exact cutoff value for high-
volume surgeons or centers remains to be elucidated.
Conclusions
In the perioperative management of surgical treatment 
of large mediastinal masses or intrathoracic tumors 
with mediastinal compression, attention to anatomical 
details of the tumor and it relations with vital mediastinal 
surrounding structures is essential. Preoperative preparation 
measures include appropriate preoperative multimodality 
imaging, with emphasis on the vascular anatomy of the 
tumor. Multidisciplinary team discussions should assess 
whether neoadjuvant therapy can be beneficial on a case-
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by-case basis. Furthermore, an assessment needs to 
be made by the anesthesiologist to evaluate the risk of 
MMS. With adequate preoperative team planning, a safe 
anesthesiological and surgical strategy can be realized. The 
management of these tumors is challenging and should be 
concentrated in specialized centers.
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